Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway

Renal ischemia-reperfusion injury (IRI) is a major cause of acute renal failure. Our previous studies have shown that pioglitazone, a peroxisome proliferators-activated receptor (PPAR)-γ agonist used in type 2 diabetes, protects against renal IRI; however, the molecular mechanism underlying the reno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenlin, Xi, Xiaoqing, Zhang, Shuangyang, Zou, Cong, Kuang, Renrui, Ye, Zhenfeng, Huang, Yawei, Hu, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088275/
https://www.ncbi.nlm.nih.gov/pubmed/30127742
http://dx.doi.org/10.3389/fphar.2018.00851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088275/
https://www.ncbi.nlm.nih.gov/pubmed/30127742
http://dx.doi.org/10.3389/fphar.2018.00851

Ejemplares similares